155
Views
0
CrossRef citations to date
0
Altmetric
Review Article

A mini review on human serum albumin - natural alkaloids interaction and its role as drug carrier

& ORCID Icon
Received 25 Oct 2023, Accepted 30 Jan 2024, Published online: 12 Feb 2024

References

  • Abbasi, S., Paul, A., Shao, W., & Prakash, S. (2012). Cationic Albumin Nanoparticles for Enhanced Drug Delivery to Treat Breast Cancer: Preparation and In Vitro Assessment. Journal of Drug Delivery, 2012, 686108. https://doi.org/10.1155/2012/686108
  • Ahmad, I., Fakhri, S., Khan, H., Jeandet, P., Aschner, M., & Yu, Z. L. (2020). Targeting cell cycle by β-carboline alkaloids in vitro: Novel therapeutic prospects for the treatment of cancer. Chemico-Biological Interactions, 330, 109229. https://doi.org/10.1016/j.cbi.2020.109229
  • Alam, M. M., Qais, F. A., Ahmad, I., Alam, P., Khan, R. H., & Naseem, I. (2018). Multi-spectroscopic and molecular modelling approach to investigate the interactionof riboflavin with human serum albumin. Journal of Biomolecular Structure & Dynamics, 36(3), 795–809. https://doi.org/10.1080/07391102.2017.1298470
  • Ansari, S. S., Khan, R. H., & Naqvi, S. (2018). Probing the intermolecular interactions into serum albumin and anthraquinone systems: A spectroscopic and docking approach. Journal of Biomolecular Structure & Dynamics, 36(13), 3362–3375. https://doi.org/10.1080/07391102.2017.1388284.
  • Ascenzi, P., & Fasano, M. (2010). Allostery in a monomeric protein: The case of human serum albumin. Biophysical Chemistry, 148(1-3), 16–22. https://doi.org/10.1016/j.bpc.2010.03.001.
  • Awad-Elkarim, A., & Means, G. E. (1988). The reactivity of p-nitrophenyl acetate with serum albumins. Comparative Biochemistry and Physiology. B, Comparative Biochemistry, 91(2), 267–272. https://doi.org/10.1016/0305-0491(88)90141-1
  • Bairagi, U., Mittal, P., & Mishra, B. (2015). Albumin: A Versatile Drug Carrier. Austin Therapeutics, 2(2), 1021.
  • Beigoli, S., Rad, S. A., Askari, A., Darban, A. R., & Chamani, J. (2019). Isothermal titration calorimetry and stopped flow circular dichroism investigations of the interaction between lomefloxacin and human serum albumin in the presenceof amino acids. Journal of Biomolecular Structure & Dynamics, 37(9), 2265–2282. https://doi.org/10.1080/07391102.2018.1491421.
  • Belinskaia, D. A., Voronina, P. A., Shmurak, V. I., Jenkins, R. O., & Goncharov, N. V. (2021). Serum albumin in health and disease: Esterase, Antioxidant, Transporting and Signaling Properties. International Journal of Molecular Sciences, 22(19), 10318. https://doi.org/10.3390/ijms221910318
  • Berezhkovskiy, L. M. (2007). On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: Determination of the possible variation of the unbound drug fraction and calculation of the number of the binding sites of the protein. Journal of Pharmaceutical Sciences, 96(2), 249–257. https://doi.org/10.1002/jps.20777.
  • Berrougui, H., Martín-Cordero, C., Khalil, A., Hmamouchi, M., Ettaib, A., Marhuenda, E., & Herrera, M. D. (2006). Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta. Pharmacological Research, 54(2), 150–157. https://doi.org/10.1016/j.phrs.2006.04.001.
  • Bertucci, C., & Domenici, E. (2002). Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance. Current Medicinal Chemistry, 9(15), 1463–1481. https://doi.org/10.2174/0929867023369673.
  • Bezerra, D. P., Pessoa, C., de Moraes, M. O., Saker-Neto, N., Silveira, E. R., & Costa-Lotufo, L. V. (2013). Overview of the Therapeutic potential of Piplartine (Piperlongumine). European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 48(3), 453–463. https://doi.org/10.1016/j.ejps.2012.12.003.
  • Bhagya, N., & Chandrashekar, K. R. (2016). Tetrandrine—A molecule of wide bioactivity. Phytochemistry, 125, 5–13. https://doi.org/10.1016/j.phytochem.2016.02.005.
  • Bhattacharjee, P., Ghosh, T., Sarkar, S., Pandya, P., & Bhadra, K. (2017). Binding affinity and in vitro cytotoxicity of of harmaline targeting different motifs of nucleic acids: AN ultimate drug designing approach. Journal of Molecular Recognition: JMR, 31(4), 10–1002. /jmr.2687. https://doi.org/10.1002/jmr.2687
  • Bhattacharjee, P., Sarkar, S., Ghosh, T., & Bhadra, K. (2018). Therapeutic potential of harmaline, a novel alkaloid, against cervical cancer cells in vitro: Apoptotic induction and DNA interaction study. J. Appl. Biol, 6(04), 1–8. https://doi.org/10.7324/JABB.2018.60401
  • Bhattacharya, A. A., Curry, S., & Franks, N. P. (2000a). Binding of the General Anesthetics Propofol and Halothane to Human Serum Albumin: High resolution crystal structures. The Journal of Biological Chemistry, 275(49), 38731–38738. https://doi.org/10.1074/jbc.M005460200.
  • Bhattacharya, A. A., Grüne, T., & Curry, S. (2000b). Crystallographic Analysis Reveals Common Modes of Binding of Medium and Long-chain Fatty Acids to Human Serum Albumin. Journal of Molecular Biology, 303(5), 721–732. https://doi.org/10.1006/jmbi.2000.4158.
  • Bhuiya, S., Haque, L., & Das, S. (2018). Association of iminium and alkanolamine forms of the benzo [c] phenanthridine alkaloid chelerythrine with human serum albumin: Photophysical, thermodynamic and theoretical approach. New Journal of Chemistry, 42(3), 2180–2196. https://doi.org/10.1039/c7nj02972a.
  • Brown, J. R. (1977). Serum albumin: Amino acid sequence. In albumin structure, functions and uses. Rosenoer, V.M., Oratz, M., & Rothschild, M.A. (eds), Pergamon press. pp 27–51.
  • Calvo, R., Carlos, R., & Erill, S. (1982). Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia. Pharmacology, 24(4), 248–252. https://doi.org/10.1159/000137603.
  • Cao, R., Peng, W., Wang, Z., & Xu, A. (2007). beta-carboline alkaloids: Biochemical and pharmacological functions. Current Medicinal Chemistry, 14(4), 479–500. https://doi.org/10.2174/092986707779940998
  • Chang, Y. L., Usami, S., Hsieh, M. T., & Jiang, M. J. (1999). Effects of palmatine on isometric force and intracellular calcium levels of arterial smooth muscle. Life Sciences, 64(8), 597–606. https://doi.org/10.1016/s0024-3205(98)00602-x.
  • Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006). Albumin binding to FcRn: Distinct from the FcRn-IgG interaction. Biochemistry, 45(15), 4983–4990. https://doi.org/10.1021/bi052628y
  • Curry, S. (2002). Beyond Expansion: Structural Studies on the Transport Roles of Human Serum Albumin. Vox Sanguinis, 83 Suppl 1(s1), 315–319. https://doi.org/10.1111/j.1423-0410.2002.tb05326.x.
  • Curry, S. (2009). Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metabolism and Pharmacokinetics, 24(4), 342–357. https://doi.org/10.2133/dmpk.24.342.
  • Daley, S-K., & Cordell, G. A. (2021). Alkaloids in contemporary drug discovery to meet global disease needs. Molecules (Basel, Switzerland), 26(13), 3800. https://doi.org/10.3390/molecules26133800
  • Dasgupta, A., & Havlik, D. (1998). Elevated free fosphenytoin concentrations in uremic sera: Uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin. Therapeutic Drug Monitoring, 20(6), 658–662. https://doi.org/10.1097/00007691-199812000-00013.
  • Deng, Y., Zhang, M., & Luo, H. (2012). Identification and antimicrobial activity of two alkaloids from traditional Chinese medicinal plant Tinospora capillipes. Industrial Crops and Products. 37(1), 298–302. https://doi.org/10.1016/j.indcrop.2011.12.006
  • Derosa, G., Maffioli, P., & Sahebkar, A. (2016). Piperine and its role in chronic diseases. Advances in Experimental Medicine and Biology, 928, 173–184. _8. https://doi.org/10.1007/978-3-319-41334-1_8
  • Dey, P., Kundu, A., Kumar, A., Gupta, M., Mu Lee, B., Bhakta, T., Dash, S., & Sik Kim, H. (2020). Recent Advances in Natural Products Analysis (pp. 505–567). Elsevier. https://doi.org/10.1016/B978-0-12-816455-6.00015-9
  • Dohare, N., Khan, A. B., Maurya, N., Thakur, S., Athar, F., Singh, P., & Patel, R. (2018). An insight into the binding of aceclofenac with bovine serum albumin at physiological condition: A spectroscopic and computational approach. Journal of Biomolecular Structure & Dynamics, 36(2), 398–406. https://doi.org/10.1080/07391102.2017.1278722.
  • Domonkos, C., Fitos, I., Visy, J., & Zsila, F. (2013). Fatty acids modulated human albumin binding of the β-carboline alkaloids norharmane and harmane. Molecular Pharmaceutics, 10(12), 4706–4716. https://doi.org/10.1021/mp400531n.
  • Elsadek, B., & Kratz, F. (2012). Impact of albumin on drug delivery–new applications on the horizon. Journal of Controlled Release: Official Journal of the Controlled Release Society, 157(1), 4–28. https://doi.org/10.1016/j.jconrel.2011.09.069
  • Emerson, T. E. Jr. (1989). Unique features of albumin A brief review. Critical Care Medicine, 17(7), 690–694. https://doi.org/10.1097/00003246-198907000-00020.
  • Faheina-Martins, G. V., da Silveira, A. L., Ramos, M. V., Marques-Santos, L. F., & Araujo, D. A. M. (2011). Influence of Fetal Bovine Serum on Cytotoxic and Genotoxic Effects of Lectins in MCF-7 Cells. Journal of Biochemical and Molecular Toxicology, 25(5), 290–296. https://doi.org/10.1002/jbt.20388.
  • Farajzadeh-Dehkordi, N., Farhadian, S., Zahraei, Z., Asgharzadeh, S., Shareghi, B., & Shakerian, B. (2023). Insights into the binding interaction of Reactive Yellow 145 with human serum albumin from a biophysics point of view. Journal of Molecular Liquids, 369, 120800. https://doi.org/10.1016/j.molliq.2022.120800
  • Farajzadeh-Dehkordi, N., Farhadian, S., Zahraei, Z., Gholamian-Dehkordi, N., & Shareghi, B. (2021). Interaction of reactive Red195 with human serum albumin: Determination of the binding mechanism and binding site by spectroscopic and molecular modeling methods. Journal of Molecular Liquids, 327, 114835. https://doi.org/10.1016/j.molliq.2020.114835
  • Farajzadeh-Dehkordi, N., Zahraei, Z., Farhadian, S., & Gholamian-Dehkordi, N. (2022). The interactions between Reactive Black 5 and human serum albumin: Combined spectroscopic and molecular dynamics simulation approaches. Environmental Science and Pollution Research International, 29(46), 70114–70124. https://doi.org/10.1007/s11356-022-20736-7
  • Farouk, L., Laroubi, A., Aboufatima, R., Benharref, A., & Chait, A. (2008). Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: Possible mechanisms involved. Journal of Ethnopharmacology. 115(3), 449–454. https://doi.org/10.1016/j.jep.2007.10.014.
  • Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S., & Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–796. https://doi.org/10.1080/15216540500404093.
  • Feroz, S. R., Mohamad, S. B., Bakri, Z. S., Malek, S. N., & Tayyab, S. (2013). Probing the interaction of a therapeutic flavonoid, pinostrobin with human serum albumin: multiple spectroscopic and molecular modeling investigations. PloS One, 8(10), e76067. https://doi.org/10.1371/journal.pone.0076067
  • Finlay, G. J., & Baguley, B. C. (2000). Effects of protein binding on the in vitro activity of antitumor acridine derivatives and related anticancer drugs. Cancer Chemotherapy and Pharmacology, 45(5), 417–422. https://doi.org/10.1007/s002800051011.
  • Fischhof, P. K., Möslinger-Gehmayr, R., Herrmann, W. M., Friedmann, A., & Russmann, D. L. (1996). Therapeutic efficacy of vincamine in dementia. Neuropsychobiology, 34(1), 29–35. https://doi.org/10.1159/000119288.
  • Frostell-Karlsson, A., Remaeus, A., Roos, H., Andersson, K., Borg, P., Hämäläinen, M., & Karlsson, R. (2000). Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. Journal of Medicinal Chemistry, 43(10), 1986–1992. https://doi.org/10.1021/jm991174y
  • Ghosh, T., Sarkar, S., Bhattacharjee, P., Jana, G. C., Hossain, M., Pandya, P., & Bhadra, K. (2020). In vitro relationship between serum protein binding to beta-carboline alkaloids: A comparative cytotoxic, spectroscopic and calorimetric assays. Journal of Biomolecular Structure & Dynamics, 38(4), 1103–1118. https://doi.org/10.1080/07391102.2019.1595727
  • Gugler, R., & Azarnoff, D. L. (1976). Drug protein binding and the nephrotic syndrome. Clinical Pharmacokinetics, 1(1), 25–35. https://doi.org/10.2165/00003088-197601010-00003.
  • Guha, S., Ghosal, S., & Chattopadhyay, U. (1996). Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy, 42(6), 443–451. https://doi.org/10.1159/000239478.
  • Hagstadius, S., Gustafson, L., & Risberg, J. (1984). The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia. Psychopharmacology, 83(4), 321–326. https://doi.org/10.1007/BF00428538.
  • Harder, S., & Thürmann, P. (1996). Clinically important drug interactions with anticoagulants. Clinical Pharmacokinetics, 30(6), 416–444. https://doi.org/10.2165/00003088-199630060-00002.
  • Ho, J. X., Holowachuk, E. W., Norton, E. J., Twigg, P. D., & Carter, D. C. (1993). X-ray and primary structure of horse serum albumin (Equus caballus) at 0.27-nm resolution. European Journal of Biochemistry, 215(1), 205–212. https://doi.org/10.1111/j.1432-1033.1993.tb18024.x
  • Hossain, M., Khan, A. Y., & Kumar, G. S. (2012). Study of the thermodynamics of the binding of iminium and alkanolamine forms of the anticancer agent sanguinarine to human serum albumin. Journal of Chemical Thermodynamics. 47, 90–99. https://doi.org/10.1016/j.jct.2011.09-026
  • Hu, Y. J., Liu, Y., & Xiao, X. H. (2009). Investigation of the Interaction between Berberine and Human Serum Albumin. Biomacromolecules, 10(3), 517–521. https://doi.org/10.1021/bm801120k.
  • Hu, Y. J., Liu, Y., Zhao, R. M., & Qu, S. S. (2005). Interaction of colchicine with human serum albumin investigated by spectroscopic methods. International Journal of Biological Macromolecules, 37(3), 122–126. / j.ijbiomac.2005.09.007. https://doi.org/10.1016/j.ijbiomac.2005.09.007
  • Ichiki, H., Miura, T., Kubo, M., Ishihara, E., Komatsu, Y., Tanigawa, K., & Okada, M. (1998). New antidiabetic compounds, mangiferin and its glucoside. Biological & Pharmaceutical Bulletin, 21(12), 1389–1390. https://doi.org/10.1248/bpb.21.1389.
  • Jafarisani, M., Bathaie, S. Z., & Mousavi, M. F. (2018). Saffron carotenoids (crocin and crocetin) binding to human serum albumin as investigated by different spectroscopic methods and molecular docking. Journal of Biomolecular Structure & Dynamics, 36(7), 1681–1690. https://doi.org/10.1080/07391102.2017.1331865.
  • Jiang, H., Chen, R., & Pu, H. (2012). Study on the interaction between tabersonine and human serum albumin by optical spectroscopy and molecular modeling methods. Journal of Luminescense, 132(3), 592–599. https://doi.org/10.1016/j.jlumin.2011.09.050
  • Kanno, S. I., Itoh, K., Suzuki, N., Tomizawa, A., Yomogida, S., & Ishikawa, M. (2013). Exogenous albumin inhibits sorafenib-induced cytotoxicity in human cancer cell lines. Molecular and Clinical Oncology, 1(1), 29–34. https://doi.org/10.3892/mco.2012.3
  • Karlsson, M. O., Dahlström, B., Eckernäs, S. A., Johansson, M., & Alm, A. T. (1990). Pharmacokinetics of oral noscapine. European Journal of Clinical Pharmacology, 39(3), 275–−279. https://doi.org/10.1007/BF00315110.
  • Khan, A. Y., Hossain, M., & Kumar, G. S. (2012). Investigations on the interaction of the phototoxic alkaloid coralyne with serum albumins. Chemosphere, 87(7), 775–781. https://doi.org/10.1016/j.chemosphere.2011.12.079
  • Khan, A. Y., Hossain, M., & Kumar, G. S. (2013). Binding of plant alkaloids berberine and palmatine to serum albumins: A thermodynamic investigation. Molecular Biology Reports, 40(1), 553–566. https://doi.org/10.1007/s11033-012-2092-z
  • Klajnert, B., & Bryszewska, M. (2002). Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin. Bioelectrochemistry, 55(1-2), 33–35. https://doi.org/10.1016/s1567-5394(01)00170-0.
  • Klammt, S., Mitzner, S. R., Stange, J., Loock, J., Heemann, U., Emmrich, J., Reisinger, E. C., & Schmidt, R. (2008). Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 14(9), 1333–1339. https://doi.org/10.1002/lt.21504
  • Kober, A., Jenner, A., & Sjöholm, I. (1978). Differentiated effects of liver cirrhosis on the albumin binding sites for diazepam, salicylic acid and warfarin. Biochemical Pharmacology, 27(23), 2729–2735. https://doi.org/10.1016/0006-2952(78)90049-7.
  • Kragh-Hansen, U. (1990). Structure and ligand binding properties of human serum albumin. Dan. Medl Bull, 37(1), 57–84. https://europepmc.org/article/med/2155760.
  • Kratz, F. (2008). Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release: Official Journal of the Controlled Release Society, 132(3), 171–183. https://doi.org/10.1016/j.jconrel.2008.05.010.
  • Kratz, F., & Elsadek, B. (2012). Clinical impact of serum proteins on drug delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society, 161(2), 429–445. https://doi.org/10.1016/j.jconrel.2011.11.028.
  • Kuete, V. (2014). 21- Health effects of alkaloids from african medicinal plants. In Kuete V. (Eds.), Toxicological Survey African Med. Plants (pp. 611–633). Elsevier. https://doi.org/10.1016/B978-0-12-800018-2.00021-2
  • Lau, A. H., Gustavson, L. E., Sperelakis, R., Lam, N. P., El-Shourbagy, T., Qian, J. X., & Layden, T. (1997). Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function. Epilepsia, 38(4), 445–451. 1528-1157.1997.tb01734.x. https://doi.org/10.1111/j.1528-1157.1997.tb01734.x
  • Leiro, J. M., Alvarez, E., Arranz, J. A., Siso, I. G., & Orallo, F. (2003). In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumor necrosis factor-alpha and transforming growth factor-beta genes. Biochemical Pharmacology, 65(8), 1361–1371. https://doi.org/10.1016/s0006-2952(03)00041-8.
  • Leung, Y. Y., Hui, L. L. Y., & Kraus, V. B. (2016). Colchicine- update on mechanisms of action and therapeutic uses. Seminars in Arthritis and Rheumatism, 45(3), 341–350. https://doi.org/10.1016/j.semarthrit.2015.06.013.
  • Li, J., Li, J., Jiao, Y., & Dong, C. (2014). Spectroscopic analysis and molecular modeling on the interaction of jatrorrhizine with human serum albumin. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 118, 48–54. saa.2013.07.029. https://doi.org/10.1016/j.saa.2013.07.029
  • Li, Y., He, W. Y., Tian, J., Tang, J., Hu, Z., & Chen, X. (2005). The effect of berberine on the secondary structure of human serum albumin. Journal of Molecular Structure, 743(1-3), 79–84. https://doi.org/10.1016/j.molstruc.2005.02.032
  • Liao, X., Zhu, C., Zhang, H., Li, X., Wen, X., Zhang, S. L., & Shen, Y. (2021). Investigation on the binding of cyanobacterial metabolite calothrixin A with human serum albumin for evaluating its potential toxicology. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 155, 112396. https://doi.org/10.1016/j.fct.2021.112396
  • Liu, Y., Li, Q. Y., Wang, Y. P., Liu, Y. M., Liu, B., Liu, M. M., & Liu, B. M. (2017). Spectroscopic investigation of the anticancer alkaloid piperlongumine binding to human serum albumin from the viewpoint of drug delivery. Luminescence: The Journal of Biological and Chemical Luminescence, 33(2), 305–311. https://doi.org/10.1002/bio.3414.
  • Lomis, N., Westfall, S., Farahdel, L., Malhotra, M., Shum-Tim, D., & Prakash, S. (2016). Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization. Nanomaterials (Basel, Switzerland), 6(6), 116. https://doi.org/10.3390/nano6060116.
  • Long, J., Song, J., Zhong, L., Liao, Y., Liu, L., & Li, X. (2019). Palmatine: A review of its pharmacology, toxicity and pharmacokinetics. Biochimie, 162, 176–184. https://doi.org/10.1016/j.biochi.2019.04.008
  • Lu, L., Huang, R., Wu, Y., Jin, J. M., Chen, H. Z., Zhang, L. J., & Luan, X. (2020). Brucine: A review of phytochemistry, pharmacology, and toxicology. Frontiers in Pharmacology, 11, 377. https://doi.org/10.3389/fphar.2020.00377.
  • Ma, X., Tan, C. H., Zhu, D., Gang, D. R., & Xiao, P. (2007). Huperzine A from Huperzia species- an ethnopharmacological review. Journal of Ethnopharmacology, 113(1), 15–34. https://doi.org/10.1016/j.jep.2007.05.030.
  • MacKichan, J. J. (2005). Influence of protein binding and use of unbound (free) drug concentrations. In Burton ME, Shaw LM, Schentag JJ, Evans WE (Eds.), Applied pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring (4th ed., pp. 82–120). Lippincott Williams & Wilkins.
  • Majorek, K. A., Porebski, P. J., Dayal, A., Zimmerman, M. D., Jablonska, K., Stewart, A. J., Chruszcz, M., & Minor, W. (2012). Structural and immunologic characterization of bovine, horse, and rabbit serum albumins. Molecular Immunology, 52(3-4), 174–182. https://doi.org/10.1016/j.molimm.2012.05.011
  • Maurya, N., Maurya, J. K., Singh, U. K., Dohare, R., Zafaryab, M., Rizvi, M. M. A., Kumari, M., & Patel, R. (2019). In vitro cytotoxicity and interaction of noscapine with human serum albumin: Effect on structure and esterase activity of HSA. Molecular Pharmaceutics, 16(3), 952–966. https://doi.org/10.1021/acs.molpharmaceut.8b00864
  • Meloun, B., Morávek, L., & Kostka, V. (1975). Complete amino acid sequence of human serum albumin. FEBS Letters, 58(1), 134–137. https://doi.org/10.1016/0014-5793(75)80242-0.
  • Mishra, V., Heath, R.J. (2021). Structural and biochemical features of human serum albumin essential for eukaryotic cell culture. International Journal of Molecular sciences22, 8411. https://doi.org/10.3390/ijms22168411.
  • Nafisi, S., Sadeghi, G.B., & Panahyab, A. (2011). Interaction of aspirin and vitamin C with bovine serum albumin. Journal of Photochemistry and Photobiology B: Biology, 105(16), 198–202. https://doi.org/10.3390/ijms22168411
  • Mistry, J., Biswas, M., Sarkar, S., & Ghosh, S. (2023). Antidiabetic activity of mango peel extract and mangiferin in alloxan-induced diabetic rats. Future Journal of Pharmaceutical Sciences, 9(1), 1–13. https://doi.org/10.1186/s43094-023-00472-6.
  • Naqvi, S. H., Lu, Y., Naqvi, W., & He, R. (2011). Treatment of bovine serum albumin with heavy metal lead rescued the SH-SH5Y Cells from the toxicity of lead. International Conference on Bioscience, Biochemistry and Bioinformatics IPCBEE. vol.5, pp 453–457, IACSIT Press.
  • Negrea, E., Oancea, P., Leonties, A., Maria, U. A., Avram, S., & Raducan, A. (2023). Spectroscopic studies on binding of ibuprofen and drotaverine with bovine serum albumin. Journal of Photochemistry and Photobiology A: Chemistry, 438, 114512. https://doi.org/10.1016/j.jphotochem.2022.114512
  • Nicholson, J. P., Wolmarans, M. R., & Park, G. R. (2000). The role of albumin in critical illness. British Journal of Anaesthesia, 85(4), 599–610. https://doi.org/10.1093/bja/85.4.599
  • Okuno, A., Kato, M., & Taniguchi, Y. (2006). The secondary structure of pressure-and temperature-induced aggregates of equine serum albumin studied by FT-IR spectroscopy. Biochimica et Biophysica Acta, 1764(8), 1407–1412. https://doi.org/10.1016/j.bbapap.2006.06.006
  • Otagiri, M. (2005). A molecular functional study on the interactions of drugs with plasma proteins. Drug Metabolism and Pharmacokinetics, 20(5), 309–323. https://doi.org/10.2133/dmpk.20.309.
  • Owen, E. A., & Keniry, M. A. (2009). Exploring the binding of Calothrixin A to the G-quadruplex from the c-myc oncogene promoter. Australian Journal of Chemistry, 62(11), 1544–1549. https://doi.org/10.1071/CH09169
  • Parvatkar, P. T. (2016). Recent progress towards the total synthesis and biological studies of calothrixin A and B. Current Organic Chemistry. 20(839), 855. https://doi.org/10.2174/1385272819666150803235103
  • Paul, M., Itoo, A. M., Ghosh, B., & Biswas, S. (2022). Current trends in the use of human serum albumin for drug delivery in cancer. Expert Opinion on Drug Delivery, 19(11), 1449–1470. https://doi.org/10.1080/17425247.2022.2134341
  • Peters, T. Jr (1996). All about Albumin. Biochemistry, Genetics, and Medical Applications. Academic Press, Inc.
  • Peters, T. Jr. (1977). Serum albumin: Recent progress in the understanding of its structure and biosynthesis. Clinical Chemistry, 23(1), 5–12. https://doi.org/10.1093/clinchem/23.1.5
  • Pontremoli, C., Barbero, N., Viscardi, G., & Visentin, S. (2018). Insight into the interaction of inhaled corticosteroids with human serum albumin: A spectroscopic-based study. Journal of Pharmaceutical Analysis, 8(1), 37–44. /j.jpha.2017.07.003. https://doi.org/10.1016/j.jpha.2017.07.003
  • Pu, H., Jiang, H., Chen, R., & Wang, H. (2014). Studies on the interaction between vincamine and human serum albumin: A spectroscopic approach. Luminescence: The Journal of Biological and Chemical Luminescence, 29(5), 471–479. https://doi.org/10.1002/bio.2572.
  • Qian, Z. M., & Ke, Y. (2014). Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease? Frontiers in Aging Neuroscience, 6, 216–210. 3389/fnagi.2014.00216. https://doi.org/10.3389/fnagi.2014.00216
  • Qu, N., Sun, Y., Li, Y., Hao, F., Qiu, P., Teng, L., Xie, J., & Gao, Y. (2019). Docetaxel-loaded human serum albumin (HSA) nanoparticles: Synthesis, characterization, and evaluation. BioMedical Engineering OnLine, 18(1), 11. https://doi.org/10.1186/s12938-019-0624-7
  • Rahman, M. H., Maruyama, T., Okada, T., Yamasaki, K., & Otagiri, M. (1993). Study of interaction of carprofen and its eneantiomers with human serum albumin-II: Stereoselective site-to-site displacement of carprofen by ibuprofen. Biochemical Pharmacology, 46(10), 1721–1731. https://doi.org/10.1016/0006-2952(93)90576-i.
  • Rahman, M. M., Rahman, M. H., & Rahman, N. N. (2005). Competitive binding of ibuprofen and naproxen to bovine serum albumin: Modified form of drug-drug displacement interaction at the binding site. Pakistan Journal of Pharmaceutical Sciences, 18(1), 43–47.
  • Sarkar, S., Bhattacharjee, P., Ghosh, T., & Bhadra, K. (2020). Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma. Future Journal of Pharmaceutical Sciences, 6(1), 1–18. https://doi.org/10.1186/s43094-020-00045-x
  • Sato, T., Kawamoto, A., Tamura, A., Tatsumi, Y., & Fujii, T. (1992). Mechanism of antioxidant action of Pueraria Glycoside (PG)-1 (an Isoflavonoid) and Mangiferin (a Xanthonoid). Chemical & Pharmaceutical Bulletin, 40(3), 721–724. https://doi.org/10.1248/cpb.40.721
  • Sebak, S., Mirzaei, M., Malhotra, M., Kulamarva, A., & Prakash, S. (2010). Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. International Journal of Nanomedicine, 5, 525–532. https://doi.org/10.2147/ijn.s10443.
  • Setoguchi, N., Takamura, N., Fujita, K., Ogata, K., Tokunaga, J., Nishio, T., Chosa, E., Arimori, K., Kawai, K., & Yamamoto, R. (2013). A diclofenac suppository-nabumetone combination therapy for the diclofenac binding capacity of HSA site II in rheumatoid arthritis. Biopharmaceutics & Drug Disposition, 34(2), 125–136. https://doi.org/10.1002/bdd.1829.
  • Shamsi, A., Shahwan, M., Khan, M. S., Alhumaydhi, F. A., Alsagaby, S. A., Al Abdulmonem, W., Abdullaev, B., & Yadav, D. K. (2022). Mechanistic insight into binding of huperzine a with human serum albumin: Computational and spectroscopic approaches. Molecules (Basel, Switzerland), 27(3), 797. https://doi.org/10.3390/molecules27030797.
  • Siddiqui, S., Ameen, F., Rehman, S., Sarwar, T., & Tabish, M. (2021). Studying the interaction of drug/ligand with serum albumin. Journal of Molecular Liquids. 336, 116200. https://doi.org/10.1016/j.molliq.2021.116200
  • Simone, G. D., Varricchio, R., Ruberto, T. F., Masi, A. D., & Ascenzi, P. (2023). Heme scavenging and delivery: The role of human serum albumin. Biomolecules, 13(3), 575. https://doi.org/10.3390/biom13030575.
  • Sleep, D., Cameron, J., & Evans, L. R. (2013). Albumin as a versatile platform for drug halflife extension. Biochimica et Biophysica Acta, 1830(12), 5526–5534. https://doi.org/10.1016/j.bbagen.2013.04.023
  • Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019). Hypoalbuminemia: Pathogenesis and clinical significance. JPEN. Journal of Parenteral and Enteral Nutrition, 43(2), 181–193. https://doi.org/10.1002/jpen.1451
  • Soundarapandian, S., Alexander, A., Pillai, A. S., Enoch, I. V. M. V., & Yousuf, S. (2022). G-Quadruplex binding of cavity-containing anthraquinonesulfonyl-β-cyclodextrin conjugate: Effect of encapsulation of ethidium bromide and berberine. Journal of Biomolecular Structure & Dynamics, 40(18), 8301–8311. https://doi.org/10.1080/07391102.2021.1911849
  • Soundrapandian, S., Ramasamy, S., Paulraj Mosae, S., & Enoch, I. V. M. V. (2019). Supramolecular complex binding to G-quadruplex DNA: Berberine encapsulated by a planar side arm-tethered β-cyclodextrin. Journal of Biomolecular Structure & Dynamics, 2019 37(13), 3305–3313. https://doi.org/10.1080/07391102.2018.1512420
  • Soundrapandian, S., Ramasamy, S., & Enoch, I. V. M. V. (2019). Molecular encapsulation of berberine by a modified β-cyclodextrin and binding of host: Guest complex to G-quadruplex DNA. Nucleosides, Nucleotides & Nucleic Acids, 38(11), 858–873. https://doi.org/10.1080/15257770.2019.1618469
  • Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., & Loscalzo, J. (1992). Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proceedings of the National Academy of Sciences of the United States of America, 89(16), 7674–7677. https://doi.org/10.1073/pnas.89.16.7674.
  • Stiborová, M., & Frei, E. (2014). Ellipticines as DNA targeted chemotherapeutics. Current Medicinal Chemistry, 21(5), 575–591. https://doi.org/10.2174/09298673113206660272.
  • Sudlow, G., Birkett, D. J., & Wade, D. N. (1975). The characterization of two specific drug binding sites on human serum albumin. Molecular Pharmacology, 11(6), 824–832.
  • Sudlow, G., Birkett, D. J., & Wade, D. N. (1976). Further Characterization of Specific Drug Binding Sites on. Human Serum Albumin. Mol. Pharmacol, 12(6), 1052–1061.
  • Sulkowska, A. (2002). Interaction of drugs with bovine and human serum albumin. Journal of Molecular Structure. 614(1-3), 227–232. https://doi.org/10.1016/S0022-2860(02)00256-9
  • Takamura, N., Maruyama, T., Chosa, E., Kawai, K., Tsutsumi, Y., Uryu, Y., Yamasaki, K., Deguchi, T., & Otagiri, M. (2005). Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: Potential for use of bucolome to restore diuretic response in nephrotic syndrome. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 33(4), 596–602. https://doi.org/10.1124/dmd.104.002782
  • Tayyab, S., & Feroz, S. R. (2021). Chapter Nine - Serum albumin: Clinical significance of drug binding and development as drug delivery vehicle. Advances in Protein Chemistry and Structural Biology, 123, 193–218. https://doi.org/10.1016/bs.apcsb.2020.08.003.
  • Thangavel, K., Lakshmikuttyamma, A., Thangavel, C., & Shoyele, S. S. (2022). CD44-targeted, indocyanine green-paclitaxel-loaded human serum albumin nanoparticles for potential image-guided drug delivery. Colloids and Surfaces. B, Biointerfaces, 209(Pt 1), 112162. https://doi.org/10.1016/j.colsurfb.2021.112162
  • Tripathi, A. K., Ray, A. K., & Mishra, S. K. (2022). Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: Evidence from clinical trials. Beni-Suef University Journal of Basic and Applied Sciences, 11(1), 16. https://doi.org/10.1186/s43088-022-00196-1
  • Valipour, M., Zarghi, A., Ebrahimzadeh, M. A., & Irannejad, H. (2021). Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19. Cell Cycle (Georgetown, Tex.), 20(22), 2321–2336. https://doi.org/10.1080/15384101.2021.1982509.
  • Varshney, A., Sen, P., Ahmad, E., Rehan, M., Subbarao, N., & Khan, R. H. (2010). Ligand binding strategies of human serum albumin: How can the cargo be utilized? Chirality, 22(1), 77–87. /chir.20709. https://doi.org/10.1002/chir.20709
  • Vereczkey, L. (1985). Pharmacokinetics and metabolism of vincamine and related compounds. European Journal of Drug Metabolism and Pharmacokinetics, 10(2), 89–103. https://doi.org/10.1007/BF03189702.
  • Wang, B. L., Pan, D. Q., Kou, S. B., Lin, Z. Y., & Shi, J. H. (2020). Exploring the binding interaction between bovine serum albumin and perindopril as well as influence of metal ions using multi-spectroscopic, molecular docking and DFT calculation. Chemical Physics, 530, 110641. https://doi.org/10.1016/j.chemphys.2019.110641
  • Wang, C., Wu, Q. H., Li, C. R., Wang, Z., Ma, J. J., Zang, X. H., & Qin, N. X. (2007). Interaction of Tetrandrine with Human Serum Albumin: A Fluorescence Quenching Study. Analytical Sciences: The International Journal of the Japan Society for Analytical Chemistry, 23(4), 429–433. https://doi.org/10.2116/analsci.23.429.
  • Wang, W., Ou, Y., & Shi, Y. (2004). AlbuBNP, a recombinant B-type natriuretic peptide andhuman serum albumin fusion hormone, as a long-term therapy of congestive heart failure. Pharmaceutical Research, 21(11), 2105–2111. https://doi.org/10.1023/b:Pham.0000048203.30568.81
  • Wang, Y. Q., Zhang, H. M., & Zhang, G. C. (2006). Studies of the interaction between palmatine hydrochloride and human serum albumin by fluorescence quenching method. Journal of Pharmaceutical and Biomedical Analysis, 41(3), 1041–1046. https://doi.org/10.1016/j.jpba.2006.01.028.
  • Wang, Y. Q., Zhang, H. M., Zhang, G. C., Tao, W. H., & Tang, S. H. (2007). Binding of brucine to human serum albumin. Journal of Molecular Structure. 830(1-3), 40–45. https://doi.org/10.1016/j.molstruc.2006.06.031
  • Wanke, R., Harjivan, S. J., Pereira, S. A., Marques, M. M., & Antunes, A. M. M. (2013). The role of competitive binding to human serum albumin on efavirenz-warfarin interaction: A nuclear magnetic resonance study. International Journal of Antimicrobial Agents, 42(5), 443–446. https://doi.org/10.1016/j.ijantimicag.2013.06.023.
  • Xu, X., Yi, H., Wu, J., Kuang, T., Zhang, J., Li, Q., Du, H., Xu, T., Jiang, G., & Fan, G. (2021). Therapeutic effect of Berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 133, 110984. https://doi.org/10.1016/j.biopha.2020.110984
  • Yamasaki, K., Chuang, V. T. G., Maruyama, T., & Otagiri, M. (2013). Albumin-drug interaction and its clinical implication. Biochimica et Biophysica Acta, 1830(12), 5435–5443. https://doi.org/10.1016/j.bbagen.2013.05.005
  • Yazdani, F., Shareghi, B., Farhadian, S., & Momeni, L. (2022). Structural insights into the binding behavior of flavonoids naringenin with Human Serum Albumin. Journal of Molecular Liquids, 349, 118431. https://doi.org/10.1016/j.molliq.2021.118431
  • Yeggoni, D. P., Rachamallu, A., Kallubai, M., & Subramanyam, R. (2015). Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α–1–acid glycoprotein. Journal of Biomolecular Structure & Dynamics, 33(6), 1336–1351. https://doi.org/10.1080/07391102.2014.947326.
  • Yin, H., & Sun, Y. H. (2011). Vincamine-producing endophytic fungus isolated from Vinca minor. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 18(8-9), 802–805. https://doi.org/10.1016/j.phymed.2011.01.005.
  • Yoosook, C., Bunyapraphatsara, N., Boonyakiat, Y., & Kantasuk, C. (2000). Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 6(6), 411–419. https://doi.org/10.1016/S0944-7113(00)80068-9.
  • Yue, Y., Chen, X., Qin, J., & Yao, X. (2009). Characterization of the mangiferin-human serum albumin complex by spectroscopic and molecular modeling approaches. Journal of Pharmaceutical and Biomedical Analysis, 49(3), 753–759. https://doi.org/10.1016/j.jpba.2008.12.017.
  • Zhang, G., Wang, A., Jiang, T., & Guo, J. (2008). Interaction of the irisflorentin with bovine serum albumin: A fluorescence quenching study. Journal of Molecular Structure. 891(1-3), 93–97. https://doi.org/10.1016/j.molstruc.2008.03.002
  • Zhang, H., Wang, R., Tan, H., Nie, L., & Yao, S. (1998). Bovine serum albumin as a means to immobilize DNA on a silver-plated bulk acoustic wave DNA biosensor. Talanta, 46(1), 171–178. https://doi.org/10.1016/s0039-9140(97)00271-3
  • Zhang, J., Wang, X. J., Yan, Y. J., & Xiang, W. S. (2011). Comparative Studies on the Interaction of Genistein, 8-Chlorogenistein, and 3',8-dichlorogenistein with Bovine Serum Albumin. Journal of Agricultural and Food Chemistry, 59(13), 7506–7513. https://doi.org/10.1021/jf2005194
  • Zhao, B., Xie, J., & Zhao, J. (2005). Binding of hypocrellin B to human serum albumin and photo-induced interactions. Biochimica et Biophysica Acta, 1722(2), 124–130. https://doi.org/10.1016/j.bbagen.2004.12.009.
  • Zhong, F., Chen, Y., Chen, J., Liao, H., Li, Y., & Ma, Y. (2021). Jatrorrhizine: A review of sources, pharmacology, pharmacookinetcis and toxicity. Frontiers in Pharmacology, 12, 783127. https://doi.org/10.3389/fphar.2021.783127.
  • Zsila, F. (2013). Subdomain IB is the third major drug binding region of human serum albumin: Toward the three-sites model. Molecular Pharmaceutics, 10(5), 1668–1682. https://doi.org/10.1021/mp400027q
  • Zsila, F., & Beke-Somfai, T. (2016). Dimeric binding of plant alkaloid ellipticine to human serum proteins. RSC Advances, 6(50), 44096–44105. https://doi.org/10.1039/C6RA06078A

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.